2024-12-012025-11-302025-11-30false03792193A.B. CHEMISTS LTD2026-08-31falseiso4217:GBPxbrli:pure037921932024-11-30037921932025-11-30037921932024-12-012025-11-30037921932023-11-30037921932024-11-30037921932023-12-012024-11-3003792193bus:SmallEntities2024-12-012025-11-3003792193bus:AuditExempt-NoAccountantsReport2024-12-012025-11-3003792193bus:FullAccounts2024-12-012025-11-3003792193bus:PrivateLimitedCompanyLtd2024-12-012025-11-3003792193core:WithinOneYear2025-11-3003792193core:AfterOneYear2025-11-3003792193core:WithinOneYear2024-11-3003792193core:AfterOneYear2024-11-3003792193core:ShareCapital2025-11-3003792193core:SharePremium2025-11-3003792193core:RevaluationReserve2025-11-3003792193core:OtherReservesSubtotal2025-11-3003792193core:RetainedEarningsAccumulatedLosses2025-11-3003792193core:ShareCapital2024-11-3003792193core:SharePremium2024-11-3003792193core:RevaluationReserve2024-11-3003792193core:OtherReservesSubtotal2024-11-3003792193core:RetainedEarningsAccumulatedLosses2024-11-3003792193core:LandBuildings2025-11-3003792193core:PlantMachinery2025-11-3003792193core:Vehicles2025-11-3003792193core:FurnitureFittings2025-11-3003792193core:OfficeEquipment2025-11-3003792193core:NetGoodwill2025-11-3003792193core:IntangibleAssetsOtherThanGoodwill2025-11-3003792193core:ListedExchangeTraded2025-11-3003792193core:UnlistedNon-exchangeTraded2025-11-3003792193core:LandBuildings2024-11-3003792193core:PlantMachinery2024-11-3003792193core:Vehicles2024-11-3003792193core:FurnitureFittings2024-11-3003792193core:OfficeEquipment2024-11-3003792193core:NetGoodwill2024-11-3003792193core:IntangibleAssetsOtherThanGoodwill2024-11-3003792193core:ListedExchangeTraded2024-11-3003792193core:UnlistedNon-exchangeTraded2024-11-3003792193core:LandBuildings2024-12-012025-11-3003792193core:PlantMachinery2024-12-012025-11-3003792193core:Vehicles2024-12-012025-11-3003792193core:FurnitureFittings2024-12-012025-11-3003792193core:OfficeEquipment2024-12-012025-11-3003792193core:NetGoodwill2024-12-012025-11-3003792193core:IntangibleAssetsOtherThanGoodwill2024-12-012025-11-3003792193core:ListedExchangeTraded2024-12-012025-11-3003792193core:UnlistedNon-exchangeTraded2024-12-012025-11-3003792193core:MoreThanFiveYears2024-12-012025-11-3003792193core:Non-currentFinancialInstruments2025-11-3003792193core:Non-currentFinancialInstruments2024-11-3003792193dpl:CostSales2024-12-012025-11-3003792193dpl:DistributionCosts2024-12-012025-11-3003792193core:LandBuildings2024-12-012025-11-3003792193core:PlantMachinery2024-12-012025-11-3003792193core:Vehicles2024-12-012025-11-3003792193core:FurnitureFittings2024-12-012025-11-3003792193core:OfficeEquipment2024-12-012025-11-3003792193dpl:AdministrativeExpenses2024-12-012025-11-3003792193core:NetGoodwill2024-12-012025-11-3003792193core:IntangibleAssetsOtherThanGoodwill2024-12-012025-11-3003792193dpl:GroupUndertakings2024-12-012025-11-3003792193dpl:ParticipatingInterests2024-12-012025-11-3003792193dpl:GroupUndertakingscore:ListedExchangeTraded2024-12-012025-11-3003792193core:ListedExchangeTraded2024-12-012025-11-3003792193dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2024-12-012025-11-3003792193core:UnlistedNon-exchangeTraded2024-12-012025-11-3003792193dpl:CostSales2023-12-012024-11-3003792193dpl:DistributionCosts2023-12-012024-11-3003792193core:LandBuildings2023-12-012024-11-3003792193core:PlantMachinery2023-12-012024-11-3003792193core:Vehicles2023-12-012024-11-3003792193core:FurnitureFittings2023-12-012024-11-3003792193core:OfficeEquipment2023-12-012024-11-3003792193dpl:AdministrativeExpenses2023-12-012024-11-3003792193core:NetGoodwill2023-12-012024-11-3003792193core:IntangibleAssetsOtherThanGoodwill2023-12-012024-11-3003792193dpl:GroupUndertakings2023-12-012024-11-3003792193dpl:ParticipatingInterests2023-12-012024-11-3003792193dpl:GroupUndertakingscore:ListedExchangeTraded2023-12-012024-11-3003792193core:ListedExchangeTraded2023-12-012024-11-3003792193dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-12-012024-11-3003792193core:UnlistedNon-exchangeTraded2023-12-012024-11-3003792193core:NetGoodwill2025-11-3003792193core:IntangibleAssetsOtherThanGoodwill2025-11-3003792193core:LandBuildings2025-11-3003792193core:PlantMachinery2025-11-3003792193core:Vehicles2025-11-3003792193core:FurnitureFittings2025-11-3003792193core:OfficeEquipment2025-11-3003792193core:AfterOneYear2025-11-3003792193core:WithinOneYear2025-11-3003792193core:ListedExchangeTraded2025-11-3003792193core:UnlistedNon-exchangeTraded2025-11-3003792193core:ShareCapital2025-11-3003792193core:SharePremium2025-11-3003792193core:RevaluationReserve2025-11-3003792193core:OtherReservesSubtotal2025-11-3003792193core:RetainedEarningsAccumulatedLosses2025-11-3003792193core:NetGoodwill2024-11-3003792193core:IntangibleAssetsOtherThanGoodwill2024-11-3003792193core:LandBuildings2024-11-3003792193core:PlantMachinery2024-11-3003792193core:Vehicles2024-11-3003792193core:FurnitureFittings2024-11-3003792193core:OfficeEquipment2024-11-3003792193core:AfterOneYear2024-11-3003792193core:WithinOneYear2024-11-3003792193core:ListedExchangeTraded2024-11-3003792193core:UnlistedNon-exchangeTraded2024-11-3003792193core:ShareCapital2024-11-3003792193core:SharePremium2024-11-3003792193core:RevaluationReserve2024-11-3003792193core:OtherReservesSubtotal2024-11-3003792193core:RetainedEarningsAccumulatedLosses2024-11-3003792193core:NetGoodwill2023-11-3003792193core:IntangibleAssetsOtherThanGoodwill2023-11-3003792193core:LandBuildings2023-11-3003792193core:PlantMachinery2023-11-3003792193core:Vehicles2023-11-3003792193core:FurnitureFittings2023-11-3003792193core:OfficeEquipment2023-11-3003792193core:AfterOneYear2023-11-3003792193core:WithinOneYear2023-11-3003792193core:ListedExchangeTraded2023-11-3003792193core:UnlistedNon-exchangeTraded2023-11-3003792193core:ShareCapital2023-11-3003792193core:SharePremium2023-11-3003792193core:RevaluationReserve2023-11-3003792193core:OtherReservesSubtotal2023-11-3003792193core:RetainedEarningsAccumulatedLosses2023-11-3003792193core:AfterOneYear2024-12-012025-11-3003792193core:WithinOneYear2024-12-012025-11-3003792193core:Non-currentFinancialInstrumentscore:CostValuation2024-12-012025-11-3003792193core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-12-012025-11-3003792193core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-12-012025-11-3003792193core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-12-012025-11-3003792193core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-12-012025-11-3003792193core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-12-012025-11-3003792193core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-12-012025-11-3003792193core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-12-012025-11-3003792193core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-12-012025-11-3003792193core:Non-currentFinancialInstrumentscore:CostValuation2025-11-3003792193core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-11-3003792193core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-11-3003792193core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-11-3003792193core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-11-3003792193core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-11-3003792193core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-11-3003792193core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-11-3003792193core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-11-3003792193core:Non-currentFinancialInstrumentscore:CostValuation2024-11-3003792193core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-11-3003792193core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-11-3003792193core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-11-3003792193core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-11-3003792193core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-11-3003792193core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-11-3003792193core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-11-3003792193core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-11-3003792193bus:Director12024-12-012025-11-3003792193core:FurnitureFittingsToolsEquipment2024-11-3003792193core:FurnitureFittingsToolsEquipment2024-12-012025-11-3003792193core:FurnitureFittingsToolsEquipment2025-11-30

A.B. CHEMISTS LTD

Registered Number
03792193
(England and Wales)

Unaudited Financial Statements for the Year ended
30 November 2025

A.B. CHEMISTS LTD
Company Information
for the year from 1 December 2024 to 30 November 2025

Director

Mr B Ampomah

Company Secretary

AMPOMAH, Claire

Registered Address

The Clock Pharmacy 1 Gayton Road
Gaywood
King's Lynn
PE30 4EA

Registered Number

03792193 (England and Wales)
A.B. CHEMISTS LTD
Balance Sheet as at
30 November 2025

Notes

2025

2024

£

£

£

£

Fixed assets
Tangible assets466,36336,991
66,36336,991
Current assets
Stocks5164,223187,627
Debtors61,280,9331,290,182
Cash at bank and on hand497,063377,334
1,942,2191,855,143
Creditors amounts falling due within one year7(911,641)(904,962)
Net current assets (liabilities)1,030,578950,181
Total assets less current liabilities1,096,941987,172
Creditors amounts falling due after one year8(2,137)(12,283)
Provisions for liabilities9(1,871)(1,871)
Net assets1,092,933973,018
Capital and reserves
Called up share capital22
Profit and loss account1,092,931973,016
Shareholders' funds1,092,933973,018
The financial statements were approved and authorised for issue by the Director on 31 August 2026, and are signed on its behalf by:
Mr B Ampomah
Director
Registered Company No. 03792193
A.B. CHEMISTS LTD
Notes to the Financial Statements
for the year ended 30 November 2025

1.Accounting policies
Statutory information
A.B. Chemists Limited is a private company, limited by shares, registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.
Basis of preparation
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, the financial reporting standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).
Turnover policy
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.
Revenue from sale of goods
Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have transferred to the buyer. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
Employee benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.
Foreign currency translation
Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.
Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date. Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.
Intangible assets
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.
Tangible fixed assets and depreciation
Tangible fixed assets are stated at cost or valuation less depreciation. Depreciation is provided on all tangible fixed assets as follows:

Reducing balance (%)
Plant and machinery25
Fixtures and fittings20
Vehicles25
Office Equipment25
Stocks and work in progress
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.
2.Average number of employees

20252024
Average number of employees during the year3129
3.Intangible assets

Goodwill

Total

££
Cost or valuation
At 01 December 241,070,0001,070,000
At 30 November 251,070,0001,070,000
Amortisation and impairment
At 01 December 241,070,0001,070,000
At 30 November 251,070,0001,070,000
Net book value
At 30 November 25--
At 30 November 24--
4.Tangible fixed assets

Plant & machinery

Vehicles

Fixtures & fittings

Office Equipment

Total

£££££
Cost or valuation
At 01 December 2478,42077,28449,13713,250218,091
Additions-46,200--46,200
At 30 November 2578,420123,48449,13713,250264,291
Depreciation and impairment
At 01 December 2477,65845,28746,74511,410181,100
Charge for year19115,70047746016,828
At 30 November 2577,84960,98747,22211,870197,928
Net book value
At 30 November 2557162,4971,9151,38066,363
At 30 November 2476231,9972,3921,84036,991
5.Stocks

2025

2024

££
Finished goods164,223187,627
Total164,223187,627
6.Debtors: amounts due within one year

2025

2024

££
Trade debtors / trade receivables695,454582,576
Amounts owed by group undertakings384,957400,434
Other debtors200,522307,172
Total1,280,9331,290,182
7.Creditors: amounts due within one year

2025

2024

££
Trade creditors / trade payables484,590483,521
Bank borrowings and overdrafts10,00011,862
Taxation and social security80,06058,990
Payments received on account334,333274,949
Other creditors2,33575,640
Accrued liabilities and deferred income323-
Total911,641904,962
8.Creditors: amounts due after one year

2025

2024

££
Bank borrowings and overdrafts2,13712,283
Total2,13712,283
9.Provisions for liabilities

2025

2024

££
Net deferred tax liability (asset)1,8711,871
Total1,8711,871
10.Related party transactions
At the yearend, BenAmp Holdings Ltd, Bampnigwe Holding Company Ltd, Clamp Investment Co Ltd, Bencas Chemist Ltd, Alan Stockley & Company Ltd, Spixworth Pharmacy Ltd, East Harling Chemist Ltd and Ben Camp Properties Ltd owed £113,725 (2024: £145,425), £79,888 (2024: £79,888), £163,435 (2024: £155,211), £NIL (2024: £86,380), £107,798 (2024: £99,798), £76,300 (2024: £76,300), £3,765 (2024: £1,890) and £6,555 (2024: NIL) respectively to A.B. Chemist Ltd. The companies are related as Mr. Benjamin Ampomah is also a director of these companies.